Madras High Court: No Appeal Lies Against E-Court Status or Adjournment Orders  ||  Chhattisgarh HC: Judicial Officer Promotion Cannot be Denied on Complaint Without Disciplinary Action  ||  Delhi High Court: January 1 as Deemed Service Date For Delhi and Andaman Civil and Police Officers  ||  Delhi High Court: Private Media Houses Performing Public Functions are Subject to Writ Jurisdiction  ||  Rajasthan High Court Orders Registration of Pets That May Pose a Threat to Human Life  ||  Delhi High Court: NSE Qualifies as a Public Authority under the RTI Act  ||  Bombay High Court: Sikh Exemption From Helmet Rule is a Reasonable Classification under Article 14  ||  Supreme Court: Advocate Cannot Enter a Compromise Without the Client’s Authorisation  ||  Calcutta High Court: State Must Protect Every Accused From Mob Violence  ||  Supreme Court: Gujarat Municipal Election Candidates Must Disclose Their Spouses’ Assets    

National Pharmaceutical Pricing Authority Notifies All Medical Devices Under Price Control - (02 Apr 2020)

LAW OF MEDICINE

National Pharmaceutical Pricing Authority has notified all medical devices sold in India as ‘drugs’ to bring the devices — such as syringes, needles, cardiac stents, a knee implant, digital thermometers, CT scan, MRIs and dialysis machines — under the purview of price control and prohibit firms from hiking their costs by more than 10% annually at a time.

Tags : NATIONAL PHARMACEUTICAL PRICING AUTHORITY   ALL MEDICAL DEVICES UNDER PRICE CONTROL  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved